etofibrate has been researched along with Carbohydrate Inducible Hyperlipemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goebel, KM; Hausmann, L; Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P | 1 |
| Altomonte, L; De Cunto, F; Greco, AV; Mingrone, G; Negrini, A | 1 |
| Altomonte, L; Ghirlanda, G; Greco, AV; Manna, R; Mingrone, G; Pala, MA; Rebuzzi, A | 1 |
| Calder, D; Luley, C; Scheffler, W; Schilling, A; Schwartzkopff, W | 1 |
1 trial(s) available for etofibrate and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged | 1981 |
3 other study(ies) available for etofibrate and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransferase; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Triglycerides; Uric Acid | 1980 |
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
Topics: Adult; Aged; Bile; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged | 1980 |
The effect of etofibrate retard, bezafibrate and procetofen.
Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Middle Aged; Patient Compliance; Propionates; Triglycerides | 1980 |